We are live on ! Find out more
FRA

Frank Rimerman Advisors Portfolio holdings

AUM $1.53B
1-Year Est. Return 30.5%
This Fund
S&P 500
This Quarter Est. Return
+11.8%
1 Year Est. Return
+30.5%
3 Year Est. Return
+108.46%
5 Year Est. Return
+120.01%
10 Year Est. Return
–
AUM
$520M
AUM Growth
+$40.2M
Cap. Flow
-$6.03M
Cap. Flow %
-1.16%
Top 10 Hldgs %
70.2%
Holding
339
New
24
Increased
27
Reduced
26
Closed
3

Top Buys

Rank Stock Value
1
QQQM icon
Invesco NASDAQ 100 ETF
QQQM
+$1.31M
2
META icon
Meta Platforms (Facebook)
META
+$1.27M
3
NVDA icon
NVIDIA
NVDA
+$1.19M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.19M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$937K

Top Sells

Rank Stock Value
1
PRCT icon
Procept Biorobotics
PRCT
+$12.6M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$1.64M
3
TSLA icon
Tesla
TSLA
+$942K
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$917K
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$421K

Sector Composition

Rank Sector Weight
1 Communication Services 14.19%
2 Technology 10.27%
3 Healthcare 2.38%
4 Financials 0.67%
5 Consumer Discretionary 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CB icon
176
Chubb
CB
$139B
$9.07K ﹤0.01%
35
– –
MCD icon
177
McDonald's
MCD
$192B
$8.74K ﹤0.01%
31
– –
PFE icon
178
Pfizer
PFE
$142B
$8.71K ﹤0.01%
314
– –
AXP icon
179
American Express
AXP
$228B
$8.65K ﹤0.01%
38
– –
MS icon
180
Morgan Stanley
MS
$333B
$8.57K ﹤0.01%
91
– –
CL icon
181
Colgate-Palmolive
CL
$73.5B
$8.46K ﹤0.01%
94
– –
LIN icon
182
Linde
LIN
$235B
$8.36K ﹤0.01%
18
– –
GS icon
183
Goldman Sachs
GS
$305B
$8.35K ﹤0.01%
20
– –
ABT icon
184
Abbott
ABT
$184B
$8.3K ﹤0.01%
73
– –
CVS icon
185
CVS Health
CVS
$137B
$7.9K ﹤0.01%
99
– –
LRCX icon
186
Lam Research
LRCX
$355B
$7.77K ﹤0.01%
80
– –
CPRT icon
187
Copart
CPRT
$27.5B
$7.64K ﹤0.01%
132
– –
BLK icon
188
Blackrock
BLK
$164B
$7.5K ﹤0.01%
9
– –
UNP icon
189
Union Pacific
UNP
$177B
$7.38K ﹤0.01%
30
– –
IFF icon
190
International Flavors & Fragrances
IFF
$19.6B
$7.31K ﹤0.01%
+85
New +$6.83K
ITW icon
191
Illinois Tool Works
ITW
$82B
$7.25K ﹤0.01%
27
– –
NOC icon
192
Northrop Grumman
NOC
$78.1B
$7.18K ﹤0.01%
15
– –
MET icon
193
MetLife
MET
$61B
$6.97K ﹤0.01%
94
– –
HIG icon
194
Hartford Financial Services
HIG
$38.5B
$6.59K ﹤0.01%
+64
New +$5.87K
ETN icon
195
Eaton
ETN
$152B
$6.57K ﹤0.01%
21
– –
ABBV icon
196
AbbVie
ABBV
$457B
$6.56K ﹤0.01%
36
– –
CTSH icon
197
Cognizant
CTSH
$22.6B
$6.08K ﹤0.01%
83
– –
BMY icon
198
Bristol-Myers Squibb
BMY
$128B
$6.07K ﹤0.01%
112
– –
PNC icon
199
PNC Financial Services
PNC
$99.3B
$5.98K ﹤0.01%
37
– –
MRSH
200
Marsh
MRSH
$88B
$5.97K ﹤0.01%
29
– –
6 7
8
9 10

Similar funds

C
Certuity North Palm Beach, Florida $1.52B AUM 37.29% 1-Year Est. Return
PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.53B AUM 21.16% 1-Year Est. Return
AF
Atlas FRM Greenwich, Connecticut $1.53B AUM 14.94% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
ACL
Azora Capital LP Miami, Florida $1.52B AUM 39.16% 1-Year Est. Return
KCM
Knighthead Capital Management New York $1.52B AUM 19.8% 1-Year Est. Return

Frank Rimerman Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Frank Rimerman Advisors held 339 positions worth $520M, up 8.4% from $479M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Frank Rimerman Advisors's Q1 2024 filing shows 24 new, 27 increased, 26 reduced and 3 closed positions. Its largest new stake was United Airlines: 2,369 shares worth $113K. The largest sale was Procept Biorobotics, an estimated $12.6M.

By sector, the portfolio is most concentrated in Communication Services at 14% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

  • Frank Rimerman Advisors's largest Q1 2024 buy was United Airlines: 2,369 shares worth $113K.
  • Frank Rimerman Advisors added most to Invesco NASDAQ 100 ETF in Q1 2024, an estimated $1.31M increase.
  • Frank Rimerman Advisors's biggest Q1 2024 reduction was Procept Biorobotics, cutting an estimated $12.6M.
  • Frank Rimerman Advisors fully exited Biogen in Q1 2024, selling an estimated $12.7K.
  • Frank Rimerman Advisors's ten largest holdings make up 70% of its $520M portfolio in Q1 2024.
  • Frank Rimerman Advisors opened 24 new positions and closed 3 in Q1 2024.
  • Frank Rimerman Advisors's portfolio value rose 8.4% quarter-over-quarter to $520M.

Based on Frank Rimerman Advisors's 13F filing for Q1 2024, filed 9 May 2024.